|
|
|||
|
||||
OverviewFull Product DetailsAuthor: F.D. King , A. W. OxfordPublisher: Elsevier Science & Technology Imprint: Elsevier Science Ltd Dimensions: Width: 15.20cm , Height: 1.90cm , Length: 21.60cm Weight: 0.581kg ISBN: 9780444511423ISBN 10: 0444511423 Pages: 300 Publication Date: 25 April 2003 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsPredicting oral absorption and bioavailability, H. van der Waterbeemd, B.C. Jones; Virtual screening of virtual libraries, D.V.S. Green; Gamma -secretase inhibitors - from molecular probes to new therapeutics, T. Harrison, D. Beher; The discovery and development of 5-HT terminal autoreceptor antagonists, J.W. Clitherow et al; Orally bioavailable beta3-adrenergic agonists as potential therapeutic agents for obesity and type II diabetes, B. Hu, L.L Jennings; Antagonists of the corticotropin releasing factor receptor, J. Saunders, J. Williams; Phosphodiesterase type 5, (PDE5) inhibitors, H. Haning, U. Niew hner, E. Bischoff.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||